Luo Y - Search Results

1

Biological knowledge graph-guided investigation of immune therapy response in cancer with graph neural network.

Zhao L, Qi X, Chen Y, Qiao Y, Bu D, Wu Y, Luo Y, Wang S, Zhang R, Zhao Y. Zhao L, et al. Among authors: luo y. Brief Bioinform. 2023 Mar 19;24(2):bbad023. doi: 10.1093/bib/bbad023. Brief Bioinform. 2023. PMID: 36682018

2

DeepOmix: A scalable and interpretable multi-omics deep learning framework and application in cancer survival analysis.

Zhao L, Dong Q, Luo C, Wu Y, Bu D, Qi X, Luo Y, Zhao Y. Zhao L, et al. Among authors: luo c, luo y. Comput Struct Biotechnol J. 2021 May 1;19:2719-2725. doi: 10.1016/j.csbj.2021.04.067. eCollection 2021. Comput Struct Biotechnol J. 2021. PMID: 34093987 Free PMC article.

3

Multi-modality artificial intelligence in digital pathology.

Qiao Y, Zhao L, Luo C, Luo Y, Wu Y, Li S, Bu D, Zhao Y. Qiao Y, et al. Among authors: luo c, luo y. Brief Bioinform. 2022 Nov 19;23(6):bbac367. doi: 10.1093/bib/bbac367. Brief Bioinform. 2022. PMID: 36124675 Free PMC article. Review.

4

TREAT: Therapeutic RNAs exploration inspired by artificial intelligence technology.

Luo Y, Liu L, He Z, Zhang S, Huo P, Wang Z, Jiaxin Q, Zhao L, Wu Y, Zhang D, Bu D, Chen R, Zhao Y. Luo Y, et al. Comput Struct Biotechnol J. 2022 Oct 8;20:5680-5689. doi: 10.1016/j.csbj.2022.10.011. eCollection 2022. Comput Struct Biotechnol J. 2022. PMID: 36320935 Free PMC article.

5

Corrigendum to "TREAT: Therapeutic RNAs exploration inspired by artificial intelligence technology" [Comput Struct Biotechnol J 20 (2022) 5680-5689].

Luo Y, Liu L, He Z, Zhang S, Huo P, Wang Z, Jiaxin Q, Zhao L, Wu Y, Zhang D, Bu D, Chen R, Zhao Y. Luo Y, et al. Comput Struct Biotechnol J. 2023 Jul 13;21:3540. doi: 10.1016/j.csbj.2023.05.018. eCollection 2023. Comput Struct Biotechnol J. 2023. PMID: 37484489 Free PMC article.

6

Delayed immune-related adverse events profile associated with immune checkpoint inhibitors: a real-world analysis.

Yang Y, Li L, Tian J, Ma L, Wu Y, Luo Q, Luo Y. Yang Y, et al. Among authors: luo y. Front Pharmacol. 2024 Nov 11;15:1453429. doi: 10.3389/fphar.2024.1453429. eCollection 2024. Front Pharmacol. 2024. PMID: 39588146 Free PMC article.

7

[Aggressive natural killer cell leukemia with hemophagocytic lymphohistiocytosis: a case report].

Yang JH, Zhou QM, Xu XY, Yao XM, Luo YM, Chen QT, Guo ZZ, Li TH. Yang JH, et al. Among authors: luo ym. Zhongguo Dang Dai Er Ke Za Zhi. 2024 Nov 15;26(11):1225-1230. doi: 10.7499/j.issn.1008-8830.2404140. Zhongguo Dang Dai Er Ke Za Zhi. 2024. PMID: 39587753 Chinese.

8

Clinical features and genetic analysis of 471 cases of fetal congenital heart disease.

Quan Y, Luo Y, Li J, Wang T, Zhang P, Li Y. Quan Y, et al. Among authors: luo y. BMC Pregnancy Childbirth. 2024 Nov 25;24(1):780. doi: 10.1186/s12884-024-06978-y. BMC Pregnancy Childbirth. 2024. PMID: 39587524

9

Genetic analysis of 280 children with unexplained developmental delay or intellectual disability using whole exome sequencing.

Xu J, Su W, Wang Y, Luo Y, Ye F, Xu Y, Chen L, Li H. Xu J, et al. Among authors: luo y. BMC Pediatr. 2024 Nov 25;24(1):766. doi: 10.1186/s12887-024-05245-5. BMC Pediatr. 2024. PMID: 39587513

10

CCDC34 maintains stemness phenotype through β-catenin-mediated autophagy and promotes EGFR-TKI resistance in lung adenocarcinoma.

Yue P, He Y, Zuo R, Gong W, Wang Y, Chen L, Luo Y, Feng Y, Gao Y, Liu Z, Chen P, Guo H. Yue P, et al. Among authors: luo y. Cancer Gene Ther. 2024 Nov 25. doi: 10.1038/s41417-024-00843-y. Online ahead of print. Cancer Gene Ther. 2024. PMID: 39587349

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29,229 results

Search Page

Filters